Everolimus is approved to treat breast cancer, pancreatic cancer, and renal cell carcinoma. It is also being studied in the treatment of other types of cancers, including multiple myeloma.
| SparkCures ID | 56 |
|---|---|
| Developed By | Novartis |
| Generic Name | Everolimus |
| Additional Names | Afinitor, RAD001 |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.